Differentiation of Human Induced Pluripotent Stem Cells into Male Germ Cells.

Human pluripotent stem cells differentiation human embryonic stem cells human induced pluripotent stem cells infertility. male germ cells

Journal

Current stem cell research & therapy
ISSN: 2212-3946
Titre abrégé: Curr Stem Cell Res Ther
Pays: United Arab Emirates
ID NLM: 101272517

Informations de publication

Date de publication:
2021
Historique:
received: 27 01 2020
revised: 21 05 2020
accepted: 26 05 2020
pubmed: 7 7 2020
medline: 30 10 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Infertility is defined as not being able to become pregnant or to conceive a child after one year or longer of regular unprotected intercourse. Male infertility refers to a male's inability to cause pregnancy that can result from deficiencies in semen quality, sperm concentration, or abnormal sperm function. Till now, there are few effective methods for the treatment of a couple with male infertility. In the past few years, stem cell-based therapy as a promising strategy has emerged for the treatment of male infertility. Human Pluripotent Stem Cells (hPSCs) can self-renew and differentiate into any type of cell. Human Embryonic Stem Cells (hESCs) and induced Pluripotent Stem Cells (hiPSCs) are two pluripotent populations that can proliferate and give rise to ectodermal, mesodermal, endodermal, and germ cell lineages. Both undifferentiated hiPSCs and hESCs are powerful candidates for the treatment of male infertility. Generation of male germ cells from hPSCs can provide new mechanistic insights into the regulation of spermatogenesis and have a great opportunity for families with infertility. Therefore, a robust, reproducible, and low-cost culture method that supports hPSCs differentiation into male germ cells is necessary. However, very few studies have focused on the derivation of sperm-like cells from hiPSCs and the details of hPSCs differentiation into male germ cells have not been fully investigated. Therefore, in this review, we focus on the in vitro differentiation potential of hiPSCs into male germ cells.

Identifiants

pubmed: 32628592
pii: CSCR-EPUB-107916
doi: 10.2174/1574888X15666200705214223
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-629

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Na Zhao (N)

Department of Gynecology, Yidu Central Hospital of Weifang, Qingzhou, Shandong 262500, China.

Min Sheng (M)

Department of Obstetrics, Yidu Central Hospital of Weifang, Qingzhou, Shandong 262500, China.

Xia Wang (X)

Department of Gynecology, Yidu Central Hospital of Weifang, Qingzhou, Shandong 262500, China.

Yonghui Li (Y)

Department of Obstetrics, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, Iran.

Maryam Farzaneh (M)

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH